KPRX
Kiora Pharmaceuticals Inc
NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY
$2.44
+3.83% today
Updated 2026-05-01
Market cap
$10.53M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$2 – $4
Volume
0.6M
Kiora Pharmaceuticals Inc (KPRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $669259.00 | $407518.00 | $1.65M | $2.69M | $12059.00 | $12059.00 | $0.00 | $0.00 | $16.00M | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | -39.1% | +305.5% | +62.5% | -99.6% | +0.0% | -100.0% | — | — | -100.0% |
| Cost of revenue | — | — | — | $1257.00 | $8.42M | $10.33M | $8.06M | $4889.00 | $3.27M | $227273.00 | $134028.00 | $4.03M | $379508.00 | $24801.00 |
| Gross profit | — | — | — | $-1257.00 | $-7.75M | $-9.92M | $-6.40M | $2.68M | $-3.26M | $-227273.00 | $-134028.00 | $-4.03M | $16.00M | $-24801.00 |
| Gross margin | — | — | — | — | -1158.5% | -2434.9% | -387.5% | 99.8% | -27038.7% | -1884.7% | — | — | 100.0% | — |
| R&D | $3.03M | $1.01M | $531116.00 | $2.72M | $8.42M | $10.33M | $8.06M | $5.39M | $3.57M | $5.35M | $3.45M | $4.03M | $4.90M | $10.78M |
| SG&A | $2.82M | $2.09M | $1.93M | $3.96M | $5.59M | $4.64M | $4.44M | $4.41M | $4.24M | $5.32M | $8.28M | $4.66M | $5.54M | $5.75M |
| Operating income | $-5.85M | $-3.10M | $-2.46M | $-6.68M | $-13.35M | $-14.56M | $-10.84M | $-7.00M | $-6.87M | $-14.24M | $-12.31M | $-12.59M | $4.51M | $-9.46M |
| Operating margin | — | — | — | — | -1994.3% | -3572.7% | -656.3% | -260.6% | -56960.5% | -118051.0% | — | — | 28.2% | — |
| EBITDA | $-5.83M | $-3.07M | $-2.24M | $-6.68M | $-13.34M | $-14.54M | $-10.69M | $-6.79M | $-7.47M | $-13.91M | $-13.65M | $-12.36M | $5.70M | $-9.43M |
| EBITDA margin | — | — | — | — | -1992.9% | -3567.8% | -646.6% | -252.7% | -61961.7% | -115359.0% | — | — | 35.6% | — |
| EBIT | $-5.84M | $-3.07M | $-2.25M | $-6.68M | $-13.34M | $-14.56M | $-10.72M | $-7.00M | $-7.51M | $-13.96M | $-13.69M | $-12.41M | $5.68M | $-9.46M |
| Interest expense | — | $611386.00 | $441720.00 | $1.93M | $275.00 | $1215.00 | $1040.00 | $325.00 | $4186.00 | $6851.00 | $8599.00 | $11132.00 | $21446.00 | $19960.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.03M | $-3.88M | $-1.77M | $-8.39M | $-13.34M | $-13.22M | $-10.81M | $-7.10M | $-6.86M | $-13.77M | $-13.58M | $-12.51M | $3.59M | $-10.84M |
| Net income growth (YoY) | — | +35.7% | +54.3% | -373.1% | -59.0% | +0.9% | +18.2% | +34.4% | +3.3% | -100.7% | +1.4% | +7.9% | +128.7% | -401.4% |
| Profit margin | — | — | — | — | -1993.8% | -3243.5% | -654.2% | -264.2% | -56901.7% | -114194.3% | — | — | 22.5% | — |